ABOUT THIS EVENT

Absci (Nasdaq: ABSI), the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, visits the Nasdaq MarketSite in Times Square. Absci’s AI-powered platform for protein discovery and production is designed to allow creation of drugs that may be impossible to make with current technologies and bring life-saving medicines to patients faster and more efficiently.

In honor of the occasion, Sean McClain, Founder & CEO, rings the Closing Bell.